Healthcare provider profile · identity verified

Dorota Wozniewicz, MD

Internal Medicine · FRANKLIN, WI · NPI 1942238696

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Losartan Potassium	Losartan Potassium	969	256
Atorvastatin Calcium	Atorvastatin Calcium	896	239
Amlodipine Besylate	Amlodipine Besylate	652	178
Levothyroxine Sodium	Levothyroxine Sodium	590	150
Pravastatin Sodium	Pravastatin Sodium	385	109
Metoprolol Succinate	Metoprolol Succinate	349	96
Lisinopril	Lisinopril	333	92
Hydrochlorothiazide	Hydrochlorothiazide	308	97
Pantoprazole Sodium	Pantoprazole Sodium	308	81
Omeprazole	Omeprazole	302	92
Simvastatin	Simvastatin	235	67
Metformin Hcl	Metformin Hcl	222	62
Gabapentin	Gabapentin	219	62
Furosemide	Furosemide	204	52
Escitalopram Oxalate	Escitalopram Oxalate	203	47
Metformin Hcl Er	Metformin Hcl	199	48
Rosuvastatin Calcium	Rosuvastatin Calcium	188	60
Alendronate Sodium	Alendronate Sodium	186	52
Atenolol	Atenolol	172	41
Eliquis	Apixaban	162	35
Metoprolol Tartrate	Metoprolol Tartrate	148	35
Albuterol Sulfate Hfa	Albuterol Sulfate	143	67
Carvedilol	Carvedilol	135	37
Citalopram Hbr	Citalopram Hydrobromide	131	34
Famotidine	Famotidine	131	41
Sertraline Hcl	Sertraline Hcl	115	27
Warfarin Sodium	Warfarin Sodium	114	28
Potassium Chloride	Potassium Chloride	110	26
Ezetimibe	Ezetimibe	109	33
Clopidogrel	Clopidogrel Bisulfate	108	31
Venlafaxine Hcl Er	Venlafaxine Hcl	106	21
Trazodone Hcl	Trazodone Hcl	104	32
Duloxetine Hcl	Duloxetine Hcl	98	19
Fluticasone Propionate	Fluticasone Propionate	98	41
Ozempic	Semaglutide	95	18
Zolpidem Tartrate	Zolpidem Tartrate	94	19
Baclofen	Baclofen	93	42
Tramadol Hcl	Tramadol Hcl	78	23
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	75	18
Buspirone Hcl	Buspirone Hcl	74	16
Donepezil Hcl	Donepezil Hcl	74	18
Montelukast Sodium	Montelukast Sodium	73	20
Jardiance	Empagliflozin	70	21
Allopurinol	Allopurinol	67	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	67	18
Spironolactone	Spironolactone	65	14
Mirtazapine	Mirtazapine	64	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	59	13
Meloxicam	Meloxicam	59	18
Alprazolam	Alprazolam	58	22
Glimepiride	Glimepiride	58	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	56	14
Tizanidine Hcl	Tizanidine Hcl	51	21
Esomeprazole Magnesium	Esomeprazole Magnesium	45	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	43	12
Lorazepam	Lorazepam	42	16
Synthroid	Levothyroxine Sodium	39	12
Valacyclovir	Valacyclovir Hcl	38	11
Amoxicillin	Amoxicillin	35	28
Bupropion Xl	Bupropion Hcl	33	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Symbicort	Budesonide/Formoterol Fumarate	32	suppressed
Clonazepam	Clonazepam	31	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	31	19
Valsartan	Valsartan	31	suppressed
Xarelto	Rivaroxaban	31	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	30	11
Diclofenac Sodium	Diclofenac Sodium	29	13
Enalapril Maleate	Enalapril Maleate	29	suppressed
Myrbetriq	Mirabegron	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Pregabalin	Pregabalin	27	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	26	suppressed
Primidone	Primidone	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Celecoxib	Celecoxib	24	suppressed
Lovastatin	Lovastatin	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Topiramate	Topiramate	22	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	22	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	21	suppressed
Naproxen	Naproxen	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	19
Ondansetron Hcl	Ondansetron Hcl	21	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Verapamil Er	Verapamil Hcl	21	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	18
Bisoprolol Fumarate	Bisoprolol Fumarate	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	11
Mounjaro	Tirzepatide	18	suppressed
Glipizide	Glipizide	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Nebivolol Hcl	Nebivolol Hcl	17	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	14
Estradiol	Estradiol	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Breyna	Budesonide/Formoterol Fumarate	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Belsomra	Suvorexant	12	suppressed
Nystatin	Nystatin	12	11
Prednisone	Prednisone	12	11
Ramelteon	Ramelteon	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Premarin	Estrogens, Conjugated	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error